deltatrials
Completed PHASE2 INTERVENTIONAL 4-arm NCT03536637

DMT310-001 Topical in the Treatment of Acne Vulgaris

A Study of Tolerability, Safety, And Efficacy, of DMT310 In Patients With Acne Vulgaris

Sponsor: Dermata Therapeutics

Conditions Acne Vulgaris
Interventions DMT310 Hydrogen Peroxide Placebo
Updated 8 times since 2018 Last updated: Jul 20, 2020 Started: May 22, 2018 Primary completion: Dec 30, 2018 Completion: Jan 28, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Acne Vulgaris and is currently completed. Dermata Therapeutics leads this study, which shows 8 recorded versions since 2018 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

~Jun 2018 – ~Jul 2018 · 30 days · monthly snapshotNot Yet Recruiting~Jul 2018 – ~Aug 2019 · 13 months · monthly snapshotRecruiting~Aug 2019 – ~Aug 2020 · 12 months · monthly snapshotCompleted~Aug 2020 – ~Jan 2021 · 5 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Sep 2025 · 12 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Sep 2024 — Sep 2025 [monthly]

    Completed PHASE2

  3. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  5. Aug 2020 — Jan 2021 [monthly]

    Completed PHASE2

▶ Show 3 earlier versions

  1. Aug 2019 — Aug 2020 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

  2. Jul 2018 — Aug 2019 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jun 2018 — Jul 2018 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

May 2018

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dermata Therapeutics
Data source: Dermata Therapeutics

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations